查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1943688

猪保健市场－全球产业规模、份额、趋势、机会及按类型、疾病、地区和竞争格局分類的预测（2021-2031年）

Swine Healthcare Market - Global Industry Size, Share, Trend, Opportunity & Forecast, Segmented By Type, By Disease, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球猪保健市场预计将从 2025 年的 31.8 亿美元成长到 2031 年的 53.1 亿美元，复合年增长率为 8.92%。

本产业涵盖动物医药、疫苗、治疗性饲料添加剂和诊断设备的研发、生产和供应，旨在保障猪隻的健康和生产力。推动该产业成长的关键因素包括全球对动物性蛋白质需求的不断增长（这需要密集养殖方式）以及迫切需要减轻严重感染疾病造成的经济损失。为了说明其中蕴含的巨大经济价值，美国国家猪肉生产者委员会 (NPPC) 的报告显示，到 2024 年，美国猪肉产业将为美国经济贡献超过 620 亿美元。

市场概览
预测期 2027-2031
市场规模：2025年 31.8亿美元
市场规模：2031年 53.1亿美元
复合年增长率：2026-2031年 8.92%
成长最快的细分市场 治疗药物
最大的市场 北美洲

儘管成长指标呈现积极态势，但由于旨在应对抗菌素抗药性的严格法律规范，该行业仍面临许多挑战。世界各地的监管机构正逐步限制抗生素的预防性使用，并对新产品的核准更为严格的标准。这些监管限制不仅缩小了农民可选择的治疗方案范围，也增加了将新型动物医药解决方案推向国际市场的成本和复杂性。

市场驱动因素

全球猪肉消费量的成长是推动生猪保健产业发展的主要因素，迫使养殖户采用集约化农业技术，而这些技术需要严格的健康管理标准。随着都市化和人口成长推动动物性蛋白质需求，生产者正在扩大营运规模，导致牲畜饲养密度增加。这就需要定期接种疫苗、驱虫和使用药用饲料添加剂，以确保猪群的存活率和运作效率。这种生产负担反映在全球产量预测中，并直接转化为兽药产品需求的成长，以确保供应的连续性。例如，美国农业部于2024年4月发布的《畜牧与家禽：全球市场与贸易》报告预测，为满足不断增长的消费者需求，2024年全球猪肉产量将达到1.156亿吨。

同时，跨境猪病疫情的日益增多迫使相关人员投入大量资源用于先进的诊断设备和预防性兽医治疗。非洲猪瘟和猪繁殖与呼吸症候群（PRRS）等病毒威胁对畜牧业资产构成严重风险，迫使该产业加强生物安全和疾病根除策略。这种对健康安全的优先重视需要对监测系统进行大量投资，以防止潜在的经济崩溃。根据猪隻健康资讯中心于2024年1月发布的《2024财政年度产业计画》，该机构专门拨款420万美元用于疾病监测和猪隻健康监测，以应对这些生物威胁。此外，国际贸易统计数据也表明，维持无病贸易的经济重要性显而易见。据美国肉类出口协会称，上年度美国猪肉出口额达到创纪录的81.6亿美元，凸显了医疗保健在支持国际贸易流动方面发挥的关键作用。

市场挑战

由于抗菌素抗药性问题日益严峻，全球猪隻保健市场面临日益严格的监管体系所带来的重大挑战。国际组织和各国政府对预防性抗生素的使用实施严格限制，同时核准设定了高标准。这种法规环境直接阻碍了市场成长，缩小了传统抗菌药物的市场规模，而这些药物一直是生产商的主要收入来源。此外，更严格的产品核可要求导致临床试验规模更大、高成本更高，延长了新治疗方法的上市时间，并减缓了养猪户的整体创新步伐。

这些倡议的实际成效体现在抗生素使用量与历史高点相比持续下降。由于生产商被迫遵守更严格的用药通讯协定，一些具有重要医疗价值的药物的使用量尚未恢復到先前的水平，这限制了製药公司在该领域的商机。例如，根据美国国家猪肉协会2024年的数据，养猪业的抗生素使用量仍比2020年下降约18%。这些数据凸显了监管要求如何从根本上限制了关键产品类型的销售前景，最终抑制了整个产业的成长。

市场趋势

随着养殖户更加重视早期检测，以最大限度地减少非洲猪瘟等疫情造成的经济损失，人工智慧驱动的疾病诊断设备的应用正在迅速改变全球养猪业的健康市场。这一趋势超越了传统的被动治疗，强调即时和基因组监测，以便在病原体扩散到整个猪群之前将其检测出来。该产业正增加对先进诊断系统的投资，这些系统利用人工智慧处理生物数据，并提供快速、准确的结果。这项转变得到了大量资金的支持：根据《国家养猪户》杂誌2025年2月刊报道，猪健康资讯中心（SHIC）将在2024年资助32个研究计划，总额达399万美元（创历史新高），这些项目旨在推进基于基因组的诊断工具和疾病监测，以确保猪群健康。

同时，有机和无抗生素养殖的推广正在重塑兽医实践，因为相关人员正在积极回应消费者对严格管理通讯协定和洁净标示肉品的需求。这一趋势正推动市场转向疫苗和植物製剂等替代疗法，以在不依赖传统抗菌药物的情况下维护动物福利。这种转变在已开发市场已取得显着成效，并促成了全球标准的建立。例如，英国兽医协会（BVA）于2025年12月宣布，养猪业已成功将抗生素使用量在2020年至2024年间减少了30%，并设定了未来四年内再减少20%的新目标。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球猪保健市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 按类型（诊断药物、治疗药物）
    • 疾病类型（渗出性皮肤炎（希腊猪病）、球虫、呼吸道疾病、猪痢疾、猪小病毒、其他）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

6. 北美猪保健市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国家分析
    • 我们
    • 加拿大
    • 墨西哥

7. 欧洲猪保健市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

8. 亚太地区猪保健市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

9. 中东和非洲猪保健市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东和非洲：国家分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

10. 南美洲猪保健市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国家分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 司机
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 最新进展

第十三章 全球猪保健市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的可能性
  • 供应商电力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Elanco Animal Health Incorporated
  • Innovative Diagnostics
  • Merck KgaA
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.
  • IDEXX Laboratories, Inc
  • Phibro Animal Health Corporation

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 23999

The Global Swine Healthcare Market is projected to expand from a valuation of USD 3.18 Billion in 2025 to USD 5.31 Billion by 2031, reflecting a compound annual growth rate of 8.92%. This sector comprises the creation, manufacture, and supply of veterinary medicines, vaccines, therapeutic feed additives, and diagnostic instruments designed to ensure the health and productivity of pig populations. Key factors fueling this growth include the rising global appetite for animal protein, which demands intensive farming methods, and the critical need to mitigate financial damages caused by severe infectious diseases. Highlighting the substantial economic stakes involved, the National Pork Producers Council reported that the United States pork industry added more than $62 billion to the economy in 2024.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 3.18 Billion
Market Size 2031USD 5.31 Billion
CAGR 2026-20318.92%
Fastest Growing SegmentTherapeutics
Largest MarketNorth America

Despite these positive growth indicators, the industry confronts significant hurdles due to rigid regulatory structures aimed at combating antimicrobial resistance. Regulatory bodies around the world are progressively limiting the preventative application of antibiotics and enforcing strict standards for the approval of new products. These regulatory constraints not only restrict the range of therapeutic choices available to farmers but also escalate the expenses and intricacies involved in introducing new veterinary medicinal solutions to the international market.

Market Driver

The escalating worldwide consumption of pork serves as a major engine for the growth of the swine healthcare industry, compelling farmers to implement intensive agricultural techniques that demand strict health management standards. As urbanization and population expansion drive up the need for animal protein, producers are expanding their operations, resulting in denser livestock populations that require the regular application of vaccines, parasiticides, and medicinal feed additives to ensure herd survival and operational efficiency. This production stress is reflected in global output forecasts, which link directly to a higher demand for veterinary health products to guarantee supply continuity. For example, the United States Department of Agriculture's 'Livestock and Poultry: World Markets and Trade' report from April 2024 projected that global pork production would hit 115.6 million tons in 2024 to satisfy this growing consumer appetite.

At the same time, the rising incidence of transboundary and infectious swine diseases compels stakeholders to commit substantial resources toward sophisticated diagnostic equipment and preventative veterinary treatments. Viral threats such as African Swine Fever and Porcine Reproductive and Respiratory Syndrome present serious risks to livestock assets, forcing the sector to emphasize biosecurity and disease elimination strategies. This prioritization of health security necessitates considerable investment in research and surveillance systems to prevent potential economic ruin. According to the Swine Health Information Center's '2024 Plan of Work' released in January 2024, the organization designated $4.2 million specifically for disease monitoring and swine health research to manage these biological threats. Moreover, the financial importance of maintaining disease-free trade status is substantial, as shown by international trade figures; the U.S. Meat Export Federation noted that U.S. pork exports achieved a record value of $8.16 billion during the previous year, highlighting healthcare's vital role in supporting global trade flows.

Market Challenge

The Global Swine Healthcare Market faces a major obstacle arising from increasingly strict regulatory systems intended to fight antimicrobial resistance. International organizations and governments are implementing rigorous restrictions on the preventative administration of antibiotics while setting high compliance benchmarks for new veterinary drugs. This regulatory climate directly hinders market growth by reducing the accessible market for traditional antimicrobial treatments, which have historically generated significant revenue for manufacturers. Additionally, the raised requirements for product authorization demand larger and more expensive clinical trials, thereby prolonging the timeline for launching new treatments and slowing the overall pace of innovation available to swine farmers.

The concrete effects of these stewardship initiatives are demonstrated by the continued reduction in antibiotic usage volumes compared to past peaks. As producers are forced to adhere to tighter usage protocols, the uptake of medically significant drugs has not rebounded to previous levels, thereby capping the revenue opportunities for pharmaceutical firms within this sector. For example, data from the National Pig Association in 2024 indicated that antibiotic use in the pig industry remained approximately 18% below the figures observed in 2020. This data point highlights how regulatory demands have fundamentally limited the sales prospects of core product categories, consequently moderating the industry's overall growth rate.

Market Trends

The integration of AI-powered disease diagnostic instruments is rapidly reshaping the Global Swine Healthcare Market as producers focus on early identification to minimize financial damages from outbreaks such as African Swine Fever. This movement transcends conventional reactive therapies, placing importance on real-time monitoring and genomic surveillance to detect pathogens before they propagate throughout a herd. The sector is seeing increased investment in advanced diagnostic systems that utilize artificial intelligence to process biological data for quicker and more precise outcomes. This transition is supported by substantial funding; as reported by National Hog Farmer in February 2025, the Swine Health Information Center financed 32 research initiatives totaling a record $3.99 million in 2024, explicitly aiming to advance genome-based diagnostic tools and disease surveillance to ensure herd well-being.

Simultaneously, the growth of organic and antibiotic-free farming methods is redefining veterinary procedures as stakeholders conform to rigorous stewardship protocols and consumer demands for clean-label meat products. This trend steers the market toward alternative treatment approaches, such as the application of vaccines and phytogenics, to uphold animal welfare without dependence on traditional antimicrobials. Forward-thinking markets are showing considerable success in this shift, establishing standards for global adherence. For example, according to the British Veterinary Association in December 2025, the pig industry successfully lowered antibiotic use by 30% from 2020 to 2024, leading to the setting of a new goal to reduce usage by a further 20% over the subsequent four years.

Key Market Players

  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animale
  • Elanco Animal Health Incorporated
  • Innovative Diagnostics
  • Merck KgaA
  • Vetoquinol SA
  • Virbac S.A.
  • Zoetis Inc.
  • IDEXX Laboratories, Inc
  • Phibro Animal Health Corporation

Report Scope

In this report, the Global Swine Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Swine Healthcare Market, By Type

  • Diagnostics
  • Therapeutics

Swine Healthcare Market, By Disease

  • Exudative dermatitis (greasy pig disease)
  • Coccidiosis
  • Respiratory Diseases
  • Swine Dysentery
  • Porcine Parvovirus
  • Other

Swine Healthcare Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Swine Healthcare Market.

Available Customizations:

Global Swine Healthcare Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Swine Healthcare Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Diagnostics, Therapeutics)
    • 5.2.2. By Disease (Exudative dermatitis (greasy pig disease), Coccidiosis, Respiratory Diseases, Swine Dysentery, Porcine Parvovirus, Other)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Swine Healthcare Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Disease
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Swine Healthcare Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Disease
    • 6.3.2. Canada Swine Healthcare Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Disease
    • 6.3.3. Mexico Swine Healthcare Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Disease

7. Europe Swine Healthcare Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Disease
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Swine Healthcare Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Disease
    • 7.3.2. France Swine Healthcare Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Disease
    • 7.3.3. United Kingdom Swine Healthcare Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Disease
    • 7.3.4. Italy Swine Healthcare Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Disease
    • 7.3.5. Spain Swine Healthcare Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Disease

8. Asia Pacific Swine Healthcare Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Disease
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Swine Healthcare Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Disease
    • 8.3.2. India Swine Healthcare Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Disease
    • 8.3.3. Japan Swine Healthcare Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Disease
    • 8.3.4. South Korea Swine Healthcare Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Disease
    • 8.3.5. Australia Swine Healthcare Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Disease

9. Middle East & Africa Swine Healthcare Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Disease
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Swine Healthcare Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Disease
    • 9.3.2. UAE Swine Healthcare Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Disease
    • 9.3.3. South Africa Swine Healthcare Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Disease

10. South America Swine Healthcare Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Disease
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Swine Healthcare Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Disease
    • 10.3.2. Colombia Swine Healthcare Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Disease
    • 10.3.3. Argentina Swine Healthcare Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Disease

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Swine Healthcare Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Boehringer Ingelheim International GmbH
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Ceva Sante Animale
  • 15.3. Elanco Animal Health Incorporated
  • 15.4. Innovative Diagnostics
  • 15.5. Merck KgaA
  • 15.6. Vetoquinol SA
  • 15.7. Virbac S.A.
  • 15.8. Zoetis Inc.
  • 15.9. IDEXX Laboratories, Inc
  • 15.10. Phibro Animal Health Corporation

16. Strategic Recommendations

17. About Us & Disclaimer